• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
FDA launches new priority review voucher program for select biopharmas

Deals

illustration of young entrepreneur pitching idea to raise venture capital fund
Biotech

Taxes, tariffs, interest rates hold key to biotech's future: EY

“This is probably one of the toughest years to predict,” Arda Ural, Ph.D., EY Americas Life Sciences Sector Leader, said on last week.
Kevin Dunleavy Jun 18, 2025 9:50am
graphic image of China flags overlapping with US flags

China's rapid rise creates 'heightened risks' for pharma: PwC

Jun 18, 2025 5:00am
Eli Lilly

Eli Lilly pays $1B upfront to buy gene editing partner Verve

Jun 17, 2025 4:35am
Photo of a final puzzle piece about to fit into a puzzle

NextCure advances ADC pivot with $745M deal for phase 1 drug

Jun 16, 2025 9:52am
AstraZeneca

AstraZeneca pens $5.3B pact with CSPC to develop oral drugs

Jun 13, 2025 5:56am
pass the torch deal sell buy acquisition

GSK offloads shigella vaccine to Bharat ahead of phase 3

Jun 12, 2025 9:18am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings